{"id":"W2161723853","doi":"10.1111/apt.13001","title":"A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Genentech; Atlantic Healthcare; Relypsa; Astellas Pharma; ActoGeniX; Shire; Bristol-Myers Squibb; Eli Lilly and Company; Orexigen Therapeutics; Biogen; Celgene; Therakos; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Takeda Oncology; Tillotts Pharma; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Receiver operating characteristic; Crohn's disease; Internal medicine; Disease; Abdominal pain; Methotrexate; Physical therapy; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02483178,0.0003860308,0.0006703527,0.002482612,0.0003732247,0.0007338749,0.0004337003,0.0003849299,0.00109925],"category_scores_gemma":[0.05224519,0.000297571,0.0008682511,0.002868915,0.0004632443,0.0006686584,0.0006597674,0.0005367612,0.0004401422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005027932,"about_ca_system_score_gemma":0.001116685,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009693631,"about_ca_topic_score_gemma":0.0006085992,"domain_scores_codex":[0.9767979,0.0133596,0.003775809,0.001603234,0.00409879,0.0003645561],"domain_scores_gemma":[0.9445665,0.02193155,0.01660702,0.006212478,0.009708609,0.0009739437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003488751,0.00004605711,0.9900267,0.0001166298,0.0001343836,0.00006067422,0.0001285782,0.00006188299,0.0001555776,0.0001634007,0.0003831199,0.008374155],"study_design_scores_gemma":[0.00009195754,0.0009708762,0.9928826,0.0001464505,0.000284871,0.0008154453,0.0002703778,0.0008626448,0.0004100219,0.0001214646,0.003127121,0.00001618504],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9687376,0.007491379,0.01362061,0.0003354718,0.0002007186,0.001683934,0.003987633,0.00005139551,0.003891333],"genre_scores_gemma":[0.9928361,0.0008315307,0.003165197,0.0001719571,0.00007764994,0.0009543622,0.001756481,0.00001456544,0.000192203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02483178,"threshold_uncertainty_score":0.1313246,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03300852250896508,"score_gpt":0.343035266853021,"score_spread":0.310026744344056,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}